{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:14:21Z","timestamp":1778818461688,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Major Projects of Guangdong Education Department for Foundation Research and Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060501"],"award-info":[{"award-number":["82060501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC200498"],"award-info":[{"award-number":["20252BAC200498"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB20392"],"award-info":[{"award-number":["20242BAB20392"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018634","name":"State Key Laboratory of Ophthalmology","doi-asserted-by":"publisher","award":["2025QZSPT41"],"award-info":[{"award-number":["2025QZSPT41"]}],"id":[{"id":"10.13039\/501100018634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018634","name":"State Key Laboratory of Ophthalmology","doi-asserted-by":"publisher","award":["2025QZLH02"],"award-info":[{"award-number":["2025QZLH02"]}],"id":[{"id":"10.13039\/501100018634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.exer.2026.110993","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:43:07Z","timestamp":1774939387000},"page":"110993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AXL inhibitor SGI-7079 suppresses the growth of retinoblastoma via PI3K\/AKT\/mTOR pathway"],"prefix":"10.1016","volume":"268","author":[{"given":"Tingting","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.110993_bib1","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4103\/ijo.IJO_721_20","article-title":"Modern treatment of retinoblastoma: a 2020 review","volume":"68","author":"Ancona-Lezama","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.110993_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nrc1753","article-title":"Oncogenic PI3K deregulates transcription and translation","volume":"5","author":"Bader","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.exer.2026.110993_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15476286.2020.1733787","article-title":"Controversies around the function of LARP1","volume":"18","author":"Berman","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.exer.2026.110993_bib4","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.ejca.2010.02.032","article-title":"Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia","volume":"46","author":"Boschelli","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exer.2026.110993_bib5","first-page":"160","article-title":"Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines","volume":"39","author":"Busch","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.exer.2026.110993_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2020.07.010","article-title":"AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer","volume":"138","author":"Cardone","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exer.2026.110993_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","article-title":"The management of retinoblastoma","volume":"37","author":"Fabian","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2026.110993_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227187","article-title":"Soluble AXL as a marker of disease progression and survival in melanoma","volume":"15","author":"Flem-Karlsen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2026.110993_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030466","article-title":"AXL receptor tyrosine kinase as a promising therapeutic target directing multiple aspects of cancer progression and metastasis","volume":"14","author":"Goyette","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exer.2026.110993_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.675703","article-title":"Publication trends of research on retinoblastoma during 2001-2021: a 20-Year bibliometric analysis","volume":"8","author":"Gu","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.exer.2026.110993_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41401-024-01237-4","article-title":"Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"45","author":"Han","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.exer.2026.110993_bib12","first-page":"1","article-title":"Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer","volume":"6","author":"Hart","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.exer.2026.110993_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154010","article-title":"PI3K\/Akt\/mTOR signaling pathway in cancer stem cells","volume":"237","author":"Karami Fath","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.exer.2026.110993_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100061","article-title":"Update on chemotherapy modalities for retinoblastoma: progress and challenges","volume":"13","author":"Kritfuangfoo","year":"2024","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"10.1016\/j.exer.2026.110993_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106668","article-title":"Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET\/MYC\/AXL axis","volume":"188","author":"Lei","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2026.110993_bib16","doi-asserted-by":"crossref","first-page":"10906","DOI":"10.1021\/acs.jmedchem.4c00400","article-title":"Discovery of dual MER\/AXL kinase inhibitors as bifunctional small molecules for inhibiting tumor growth and enhancing tumor immune microenvironment","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2026.110993_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.exer.2026.110993_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116475","article-title":"Recent discovery and development of AXL inhibitors as antitumor agents","volume":"272","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exer.2026.110993_bib19","first-page":"4155","article-title":"Computational and immunohistochemical analyses highlight AXL as a potential prognostic marker for ovarian cancer patients","volume":"36","author":"Lozneanu","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.exer.2026.110993_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"10.1016\/j.exer.2026.110993_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/IJO.IJO_2414_23","article-title":"Retinoblastoma - a comprehensive review, update and recent advances","volume":"72","author":"Nag","year":"2024","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.110993_bib22","first-page":"5016","article-title":"Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase","volume":"11","author":"O'Bryan","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2026.110993_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0883073815587943","article-title":"Retinoblastoma","volume":"31","author":"Ortiz","year":"2016","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.exer.2026.110993_bib24","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/neurintsurg-2019-014909","article-title":"Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis","volume":"11","author":"Ravindran","year":"2019","journal-title":"J. Neurointerventional Surg."},{"key":"10.1016\/j.exer.2026.110993_bib25","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2026.110993_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11912-017-0579-4","article-title":"Key roles of AXL and MER receptor tyrosine kinases in resistance to multiple anticancer therapies","volume":"19","author":"Schoumacher","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.exer.2026.110993_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molimm.2023.05.005","article-title":"AXL-Induced autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K\/AKT\/mTOR signaling pathway","volume":"159","author":"Sun","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.exer.2026.110993_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189953","article-title":"Therapeutic targeting of the Gas6\/Axl signaling pathway in cancer","volume":"22","author":"Tanaka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.110993_bib29","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.110993_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40164-024-00566-8","article-title":"AXL as immune regulator and therapeutic target in acute myeloid leukemia: from current progress to novel strategies","volume":"13","author":"Vandewalle","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.exer.2026.110993_bib31","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11841","article-title":"SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K\/AKT pathway","volume":"23","author":"Wang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exer.2026.110993_bib32","first-page":"2160","article-title":"Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206","volume":"12","author":"Wang","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.exer.2026.110993_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119928","article-title":"AXL kinase inhibitor exhibits antitumor activity by inducing apoptotic cell death in triple-negative breast cancer cells","volume":"1872","author":"Woo","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.exer.2026.110993_bib34","first-page":"2950","article-title":"Rapamycin inhibits proliferation and apoptosis of retinoblastoma cells through PI3K\/AKT signaling pathway","volume":"19","author":"Yao","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.exer.2026.110993_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/bjc.2015.237","article-title":"Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma","volume":"113","author":"Yu","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.exer.2026.110993_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100058","article-title":"Recent progress in retinoblastoma: pathogenesis, presentation, diagnosis and management","volume":"13","author":"Zhou","year":"2024","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"10.1016\/j.exer.2026.110993_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:48:48Z","timestamp":1778816928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0014483526001491"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.110993","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AXL inhibitor SGI-7079 suppresses the growth of retinoblastoma via PI3K\/AKT\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.110993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110993"}}